Organogenesis Holdings Inc. to Participate in the ICR Conference 2021
05 janv. 2021 16h05 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. Announces Pricing of Public Offering of Class A Common Stock
13 nov. 2020 00h45 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. Announces Proposed Public Offering of Class A Common Stock
10 nov. 2020 17h40 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. Reports Third Quarter and Nine Months 2020 Financial Results
09 nov. 2020 16h05 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Latest Wound Care Research from Organogenesis Highlighted at SAWC Fall 2020 Virtual Meeting
02 nov. 2020 16h30 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...
Organogenesis Holdings Inc. Reports Preliminary Financial Results for Third Quarter 2020
14 oct. 2020 16h30 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. Updates Date and Time of Presentation at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
17 sept. 2020 16h05 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
03 sept. 2020 16h05 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
Organogenesis Holdings Inc. Announces Management Change
24 août 2020 16h05 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. Reports Second Quarter and First Half 2020 Financial Results
10 août 2020 16h05 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...